Resources

In part 2 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the current usefulness of the A1C test.

In part 3 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the usefulness of CGMs for people who are not on insulin therapy.

In part 4 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the latest treatments and possible treatments coming down the pike in diabetes care.

In part 5, the conclusion of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about diabetes and cardiovascular combo therapy, and how new medications and precision medicine are changing diabetes care.

Elevated eGR fund to possibly lead to renal damage.

Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucose

Patients who have normoglycemia still at risk for glucose spikes and diabetes.

Study investigates preservation or improvement of B-cell function using metformin with or without short-term insulin.

Guest Post by David Kliff, Editor, Diabetic Investor
This weekend, the most dedicated people in diabetes will gather in Baltimore for the AADE conference. Year after year, these amazing people gather to see all the latest toys in the toy chest, learn about all the new drugs, and share insights into how they are impacting the lives of the patients they work with.

Would you be more open to prescribing a GLP-1 Inhibitor if there was an oral product rather than an injectable? Follow the link to share your opinion and see what your colleagues think.